Terumo Gets Its Toe Wet in the US Cardiovascular Market
Executive Summary
Terumo is a major device company in Japan, but has to date had little success in building a US business. With the acquisition of 3M's cardiovascular business, is Terumo taking its first major step toward building a greater US presence?
You may also be interested in...
Business & Technology Briefs (03/2007)
Brief summaries of recent product and clinical developments in the device industry, including developments in Cardiac and Peripheral Devices, Miniature Robotic Devices, and Diabetes Management.
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.